Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

The hydrogel helps wounds heal without scars and promotes new hair growth.

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

Vitiligo and alopecia areata may have similar causes despite their differences.

Advancements in gene therapy, stem cells, and biomaterials show promise for reducing scarring in wound healing, but face clinical challenges.

Imbalanced skin bacteria worsen diabetic foot ulcers, but adjusting them might improve healing.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Alopecia areata in Saudi Arabia is costly, mainly due to lost productivity and drug costs.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Stem cell treatment from umbilical cords reduces symptoms of atopic dermatitis and may help hair growth.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Unmodified fullerene C60 promotes hair growth and may help treat hair loss.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Tiny vesicles from stem cells could be a new treatment for healing wounds.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Acne treatment with isotretinoin increases the presence of p53, a protein, in skin and oil glands, which may help reduce acne severity.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

Aligned membranes improve wound healing by reducing scars and promoting skin regeneration.

taVNS reduces vitiligo symptoms in mice.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Tiny particles improved delivery of hair loss treatments to hair follicles, with lipid-based particles performing best.